Recursion Pharmaceuticals Inc (RXRX)
7 tracked managers currently hold RXRX on their latest filing. Change is versus that manager’s previous filing. Reported as of quarter end, filed up to ~45 days later, not live positions.
Sort: Size Weight change
Sorted by reported value on the latest filing.
| Manager | Period | Change | Value | Weight | Prev weight | Shares | Δ shares |
|---|---|---|---|---|---|---|---|
| ARK Investment Management LLC | Q3 2026 | ADD | $184.8M | 1.1 % | 1.0 % | 44,745,025 | +3,407,393 |
| TWO SIGMA INVESTMENTS, LP | Q3 2026 | ADD | $32.8M | 0.0 % | 0.0 % | 7,951,077 | +4,597,419 |
| MILLENNIUM MANAGEMENT LLC | Q3 2026 | ADD | $16.7M | 0.0 % | 0.0 % | 4,044,850 | +2,210,088 |
| CITADEL ADVISORS LLC | Q3 2026 | ADD | $12.2M | 0.0 % | 0.0 % | 2,962,097 | +2,833,619 |
| Point72 Asset Management, L.P. | Q3 2026 | NEW | $984.7K | 0.0 % | — | 238,435 | NEW |
| Bridgewater Associates, LP | Q3 2026 | ADD | $398.9K | 0.0 % | 0.0 % | 96,596 | +58,929 |
| D. E. Shaw & Co., Inc. | Q3 2026 | TRIM | $69.3K | 0.0 % | 0.0 % | 16,771 | -21,143 |